(2S,3R)-3-{[(2S,3R,4R,5R,6R)-3-Acetamido-4,5-diacetoxy-6-(acetoxymethyl)tetrahydro-2H-pyran-2-yl]oxy}-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}butanoic acid(CAS: 116783-35-8)

This compound (CAS: 116783-35-8) falls under GHS classification as a hazardous substance due to its chemical structure. Regulatory requirements include compliance with REACH in the EU for registration, evaluation, authorization, and restriction of chemicals. In the US, FDA and EPA regulations apply for pharmaceutical and environmental safety. Specific handling and storage guidelines are necessary to ensure safety and compliance.

Alternatives to this compound (CAS: 116783-35-8) include similar functionalized derivatives or isomers with slight modifications. Common alternative reagents include other acylated amino acids or related compounds with simpler structures. These alternatives can offer similar reactivity while varying in complexity and synthesis cost.

Research trends for this compound (CAS: 116783-35-8) are focused on its potential applications in drug discovery and development, particularly in medicinal chemistry and bioconjugation. Market interest is growing due to its unique chemical properties. However, its high synthesis cost and complexity may limit widespread use. Emerging studies explore its use in targeted drug delivery systems and as a template for new drug candidates.

Waste containing this compound (CAS: 116783-35-8) should be collected in appropriate containers and labeled as hazardous. Incineration or professional waste disposal services should be used for safe disposal. Environmental protection measures include minimizing exposure to air and water during handling. Proper personal protective equipment (PPE) and safety protocols must be followed to prevent contamination and ensure worker safety.